WILSON KAREN J has filed 8 insider transactions across 3 companies since December 2023.
Most recent transaction: a disposition of 10000 shares of LAVA Therapeutics NV ($LVTX) on November 13, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2025 | LAVA Therapeutics NV | $LVTX | WILSON KAREN J | Not found | D | Common Shares | 10000 | $0.00 | 0.0000 | 26,899,122 | 100.00% | 0.04% |
| Nov. 13, 2025 | LAVA Therapeutics NV | $LVTX | WILSON KAREN J | Not found | D | Share Options (Right to Buy) | 33390 | $0.00 | 0.0000 | 26,899,122 | 100.00% | 0.12% |
| Nov. 7, 2025 | Serina Therapeutics, Inc. | $SER | WILSON KAREN J | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 10,339,000 | 9999.99% | 0.10% |
| May 19, 2025 | Elicio Therapeutics, Inc. | $ELTX | WILSON KAREN J | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| Feb. 13, 2025 | LAVA Therapeutics NV | $LVTX | WILSON KAREN J | Not found | A | Common Shares (Right to Buy) | 33390 | $0.00 | 33,390.0000 | 26,834,422 | 9999.99% | 0.12% |
| Jan. 14, 2025 | Serina Therapeutics, Inc. | $SER | WILSON KAREN J | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,359,000 | 9999.99% | 0.54% |
| Nov. 21, 2024 | Elicio Therapeutics, Inc. | $ELTX | WILSON KAREN J | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Elicio Therapeutics, Inc. | $ELTX | WILSON KAREN J | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |